Related Experiment Video
Updated: Jan 4, 2026

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021
C99 selectively accumulates in vulnerable neurons in Alzheimer's disease
Maria V Pulina1, Maya Hopkins1, Vahram Haroutunian2,3
1Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, USA.
Introduction:
The levels and distribution of amyloid deposits in the brain does not correlate well with Alzheimer's disease (AD) progression. Therefore, it is likely that amyloid precursor protein and its proteolytic fragments other than amyloid b (Ab) contribute to the onset of AD.
Methods:
We developed a sensitive assay adapted to the detection of C99, the direct precursor of b-amyloid. Three postmortem groups were studied: control with normal and stable cognition; patients with moderate AD, and individuals with severe AD. The amount of C99 and Aβ was quantified and correlated with the severity of AD.
Results:
C99 accumulates in vulnerable neurons, and its levels correlate with the degree of cognitive impairment in patients suffering from AD. In contrast, Aβ levels are increased in both vulnerable and resistant brain areas.
Discussion:
These results raise the possibility that C99, rather than Aβ plaques, is responsible for the death of nerve cells in AD.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment

